Higher Drug Survival Rates in Patients with Psoriasis Utilizing Etanercept Compared to Adalimumab – a Nationwide Population-Based Cohort Study in Sweden

Nov 1, 2015, 00:00 AM
10.1016/j.jval.2015.09.1011
https://www.valueinhealthjournal.com/article/S1098-3015(15)03087-9/fulltext
Section Title : Research Podium Presentations - Session 1 and Session 2
Section Order : 449
First Page : A416
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)03087-9&doi=10.1016/j.jval.2015.09.1011
HEOR Topics :
Tags :
Regions :